Get the free version of Marbridge Daily delivered to your inbox

Click here to subscribe

BGI Genomics Seeks to Raise RMB 547 Mln in Shenzhen IPO

BGI Genomics, 7/13/17

Shenzhen-based genetic testing company BGI Genomics has announced that the company will IPO on the Shenzhen stock exchange tomorrow, seeking to raise approximately RMB 547 mln, floating no more than 10.02% of the company's equity.

BGI Genomics, which will trade under the 300676 ticker, is looking to sell 40.1 mln newly issued shares at a price of RMB 13.64 per share.

BGI Genomics provides genomic diagnostics and research services for medical institutions, research institutions, and corporations, primarily through gene testing.

Company founder Wang Jian holds an 85.3% stake in BGI Holdings, which in turn directly and indirectly holds a 42.42% stake in BGI Genomics.

Considering the current state of business development, operations plans, and the expenses of a public listing, BGI Genomics estimates that it will generate revenue of RMB 872 mln in H1 2017, up 13.84% YoY, and net profit of RMB 175 mln, up 17.45% YoY.

Keywords: online healthcare Wang Jian Internet IPO revenue BGI Genomics H1 2017 300676.SZ


Please note, all fields are required.
None of your personal information will be shared with third parties.


Marbridge Daily Premium

Interested in gaining full access to all newsletter articles and the Marbridge Daily archive? To learn more about premium subscription options, including pricing, please:

Click here

Marbridge Consulting RSS Feed

Marbridge Reports